FGF2 and interstitial lung disease: We wanted to explore whether Nintedanib predominately targeted proteins (PDGF-AA, PDGF-BB, FGF-2, VEGF, and M-CSF) were elevated in whole lung homogenates from IPF, SSc-ILD and other PF-ILD compared to healthy donors.